Truist Securities maintains Regeneron Pharmaceuticals (NASDAQ:REGN) $1045 price target

By / / Regeneron Pharmaceuticals, Truist Financial

Truist Securities analyst Robyn Karnauskas reiterates Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and maintains $1045 price target.

Scroll to Top